Erschienen in:
04.08.2022 | ASO Author Reflections
ASO Author Reflections: How Immunotherapy Could Change the Management of Responsive Solid Tumors
verfasst von:
Nicholas D. Klemen, MD, Michael I. D’Angelica, MD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 13/2022
Einloggen, um Zugang zu erhalten
Excerpt
Responses to immunotherapy are unique from what has historically been observed with cytotoxic chemotherapy. The latter rarely mediate durable tumor regression, although it can eradicate occult micrometastatic disease in some patients. By contrast, when immunotherapy results in a complete radiographic response, it is often durable and recurrence is the exception. These results demonstrate the ablative potential of immunotherapy in well-selected patients, which can sterilize (or at least durably suppress) even large volumes of metastatic disease. …